All Columns articles – Page 40
-
OpinionDown to business
To make the economic case for research, scientists need to understand how commercialisation works, says Mark Peplow
-
Opinion(–)-Jiadifenolide
BRSM wonders what makes a route so good it becomes the last total synthesis of a complex target
-
-
Opinion
Taking responsibility seriously
Companies have a duty to be proactive when it comes to sustainability
-
OpinionThe RSC hits the WWW
The Royal Society of Chemistry launched it’s online presence at a ceremony in Cambridge
-
-
-
OpinionPop culture
Fizzy drinks were an instant hit, but could their tongue-tingling success be captured in solid form?
-
Opinion
Points of view
A survey of public attitudes to chemistry reveals misconceptions on both sides
-
-
OpinionDispelling nickel’s catalytic demons
Stable Ni(IV) complexes could help nickel rival its flashier platinum-group cousins, says Karl Collins
-
-
OpinionEurope's science advice, redux
Will a new expert panel be any more effective than a chief science adviser, wonders Mark Peplow
-
OpinionMissing the target
There are plenty of things that small molecule drugs can’t touch, says Derek Lowe, and it’s not for want of trying
-
OpinionA coat of many colours
Just how did lab couture settle on that little white number, asks Philip Ball
-
-
OpinionMagic molecule modifiers
Late stage functionalisation can seem supernaturally powerful, says Derek Lowe – if you’ve got the nerve to try it
-
